Open AccessFourteen-vsseven-day bismuth-based quadruple therapy for second-lineHelicobacter pylorieradication
Author(s) -
Jae Chul Hwang,
Dong Hoon Lee,
Ae-Ra Lee,
Hyuk Yoon,
Cheol Min Shin,
Young Soo Park,
Nayoung Kim
Publication year - 2015
Publication title -
world journal of gastroenterology
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v21.i26.8132
Subject(s) - helicobacter pylori , medicine , metronidazole , gastroenterology , urea breath test , rabeprazole , intention to treat analysis , esomeprazole , breath test , proton pump inhibitor , surgery , helicobacter pylori infection , adverse effect , antibiotics , microbiology and biotechnology , biology
To compare the efficacy of 14- and 7-d bismuth-based quadruple therapies as second-line eradication treatment for Helicobacter pylori (H. pylori) infection.